Shingles vaccine study for adults 40 and older
Part of Infections clinical trials.
This trial tests a new shingles vaccine in adults 40 and older to see if it is safe and works well. The vaccine is designed to prevent shingles and its complications, which are common in this age group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years of age or older.
- You must be able to understand and sign the consent form.
- Your armpit temperature must be 37.0°C or lower on the day of vaccination.
- You must not have a weakened immune system due to disease or treatments like chemotherapy or radiation.
- You must not have had a shingles or chickenpox vaccine before.
- If you are a woman who can have children, you must not be pregnant, planning to become pregnant in the next 6 months, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This study tests an investigational vaccine (SYS6017) to see how well it works and if it's safe for adults 40 and older. The vaccine aims to prevent shingles, a painful rash caused by the same virus as chickenpox.
This study tests a new vaccine to prevent shingles (a painful rash condition) in adults 50 and older. It checks how safe the vaccine is and how well it triggers the body's immune defense.
Hear when a new Prevention of Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.